HEADER TRANSFERASE/INHIBITOR 31-AUG-15 5DI1 TITLE MAP4K4 IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1-310; COMPND 5 SYNONYM: HPK/GCK-LIKE KINASE HGK,MAPK/ERK KINASE KINASE KINASE 4, COMPND 6 MEKKK 4,NCK-INTERACTING KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K4, HGK, KIAA0687, NIK; SOURCE 6 EXPRESSION_SYSTEM: INSECT CELL EXPRESSION VECTOR PTIE1; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 266783 KEYWDS KINASE, INHIBITOR, COMPLEX, MEDICINAL CHEMISTRY, TRANSFERASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU REVDAT 2 27-SEP-23 5DI1 1 REMARK REVDAT 1 13-JAN-16 5DI1 0 JRNL AUTH M.AMMIRATI,S.W.BAGLEY,S.K.BHATTACHARYA,L.BUCKBINDER, JRNL AUTH 2 A.A.CARLO,R.CONRAD,C.CORTES,R.L.DOW,M.S.DOWLING,A.EL-KATTAN, JRNL AUTH 3 K.FORD,C.R.GUIMARAES,D.HEPWORTH,W.JIAO,J.LAPERLE,S.LIU, JRNL AUTH 4 A.LONDREGAN,P.M.LORIA,A.M.MATHIOWETZ,M.MUNCHHOF,S.T.ORR, JRNL AUTH 5 D.N.PETERSEN,D.A.PRICE,A.SKOURA,A.C.SMITH,J.WANG JRNL TITL DISCOVERY OF AN IN VIVO TOOL TO ESTABLISH PROOF-OF-CONCEPT JRNL TITL 2 FOR MAP4K4-BASED ANTIDIABETIC TREATMENT. JRNL REF ACS MED.CHEM.LETT. V. 6 1128 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26617966 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00215 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 15427 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 756 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.92 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1952 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2673 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1860 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE : 0.3556 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.71 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 92 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4714 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 35 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 74.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.33140 REMARK 3 B22 (A**2) : 2.90820 REMARK 3 B33 (A**2) : -6.23960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.434 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.404 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4869 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6600 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1706 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 121 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 693 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4869 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 623 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5502 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.26 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.91 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.25 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|14 - A|173 A|186 - A|309 } REMARK 3 ORIGIN FOR THE GROUP (A): 73.4592 46.2268 11.1642 REMARK 3 T TENSOR REMARK 3 T11: -0.1510 T22: -0.0732 REMARK 3 T33: 0.0029 T12: 0.0044 REMARK 3 T13: 0.1097 T23: 0.0139 REMARK 3 L TENSOR REMARK 3 L11: 0.7301 L22: 3.8626 REMARK 3 L33: 2.3008 L12: 0.7642 REMARK 3 L13: 0.5852 L23: 1.9217 REMARK 3 S TENSOR REMARK 3 S11: 0.0060 S12: 0.0337 S13: 0.1441 REMARK 3 S21: 0.0530 S22: -0.0316 S23: 0.2799 REMARK 3 S31: -0.2654 S32: -0.0276 S33: 0.0256 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|10 - B|309 } REMARK 3 ORIGIN FOR THE GROUP (A): 101.4070 32.8459 22.1955 REMARK 3 T TENSOR REMARK 3 T11: -0.1130 T22: -0.1063 REMARK 3 T33: -0.0359 T12: -0.0956 REMARK 3 T13: -0.0546 T23: -0.0639 REMARK 3 L TENSOR REMARK 3 L11: 3.3809 L22: 1.3050 REMARK 3 L33: 2.7203 L12: -0.6744 REMARK 3 L13: -0.7955 L23: 0.1505 REMARK 3 S TENSOR REMARK 3 S11: 0.0391 S12: -0.2057 S13: 0.4073 REMARK 3 S21: 0.2837 S22: 0.0720 S23: -0.1970 REMARK 3 S31: -0.4201 S32: 0.4634 S33: -0.1110 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DI1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213224. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15489 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 45.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.36600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1F3M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM HEPES PH7.0, 0.3 M NACL, 30% PEG REMARK 280 NNE 2000M 0.1 M KSCN, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.30000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.31000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.87000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.31000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.30000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.87000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASN A 3 REMARK 465 ASP A 4 REMARK 465 SER A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 LYS A 8 REMARK 465 SER A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 ASP A 12 REMARK 465 VAL A 174 REMARK 465 SER A 175 REMARK 465 ALA A 176 REMARK 465 GLN A 177 REMARK 465 LEU A 178 REMARK 465 ASP A 179 REMARK 465 ARG A 180 REMARK 465 THR A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ARG A 184 REMARK 465 ARG A 185 REMARK 465 ARG A 310 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 ASP B 4 REMARK 465 SER B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 LYS B 8 REMARK 465 SER B 9 REMARK 465 ARG B 310 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 93 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 22 -83.62 -23.21 REMARK 500 ASN A 33 -97.98 -103.12 REMARK 500 GLN A 38 50.96 -91.47 REMARK 500 HIS A 78 55.68 -104.59 REMARK 500 PRO A 95 -9.20 -53.14 REMARK 500 HIS A 97 168.50 57.11 REMARK 500 ARG A 152 -23.06 79.65 REMARK 500 ASP A 171 52.20 72.53 REMARK 500 ASN A 205 68.62 -113.72 REMARK 500 ALA A 208 96.10 6.07 REMARK 500 PRO A 232 -31.99 -39.79 REMARK 500 LEU A 270 39.74 -96.66 REMARK 500 VAL B 11 -170.10 -67.05 REMARK 500 ASP B 12 -16.49 72.58 REMARK 500 VAL B 31 -66.07 -107.22 REMARK 500 TYR B 36 31.77 -148.02 REMARK 500 GLN B 38 83.13 70.94 REMARK 500 VAL B 45 36.95 -65.89 REMARK 500 LYS B 46 -73.26 -116.90 REMARK 500 THR B 47 103.28 -173.39 REMARK 500 GLN B 49 152.58 -49.55 REMARK 500 LYS B 92 85.96 -63.81 REMARK 500 SER B 93 144.32 -170.72 REMARK 500 LYS B 121 -69.07 11.08 REMARK 500 ARG B 152 -20.55 76.67 REMARK 500 ASN B 164 -100.47 -87.76 REMARK 500 ALA B 165 31.17 -166.91 REMARK 500 GLU B 204 -23.33 96.11 REMARK 500 ALA B 208 95.17 6.83 REMARK 500 LEU B 233 12.67 89.87 REMARK 500 LEU B 270 40.62 -97.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5DF A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZP5 RELATED DB: PDB REMARK 900 MAP4K4 IN COMPLEX WITH A RELATED INHIBITOR DBREF 5DI1 A 1 310 UNP O95819 M4K4_HUMAN 1 310 DBREF 5DI1 B 1 310 UNP O95819 M4K4_HUMAN 1 310 SEQRES 1 A 310 MET ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP ILE SEQRES 2 A 310 ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE GLU SEQRES 3 A 310 LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN VAL SEQRES 4 A 310 TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA ALA SEQRES 5 A 310 ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU GLU SEQRES 6 A 310 ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER HIS SEQRES 7 A 310 HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE LYS SEQRES 8 A 310 LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU VAL SEQRES 9 A 310 MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU VAL SEQRES 10 A 310 LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP ILE SEQRES 11 A 310 ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA HIS SEQRES 12 A 310 LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS GLY SEQRES 13 A 310 GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS LEU SEQRES 14 A 310 VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR VAL SEQRES 15 A 310 GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP MET SEQRES 16 A 310 ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP ALA SEQRES 17 A 310 THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY ILE SEQRES 18 A 310 THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU CYS SEQRES 19 A 310 ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO ARG SEQRES 20 A 310 ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER LYS SEQRES 21 A 310 LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS ASN SEQRES 22 A 310 TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS HIS SEQRES 23 A 310 PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL ARG SEQRES 24 A 310 ILE GLN LEU LYS ASP HIS ILE ASP ARG THR ARG SEQRES 1 B 310 MET ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP ILE SEQRES 2 B 310 ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE GLU SEQRES 3 B 310 LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN VAL SEQRES 4 B 310 TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA ALA SEQRES 5 B 310 ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU GLU SEQRES 6 B 310 ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER HIS SEQRES 7 B 310 HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE LYS SEQRES 8 B 310 LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU VAL SEQRES 9 B 310 MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU VAL SEQRES 10 B 310 LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP ILE SEQRES 11 B 310 ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA HIS SEQRES 12 B 310 LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS GLY SEQRES 13 B 310 GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS LEU SEQRES 14 B 310 VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR VAL SEQRES 15 B 310 GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP MET SEQRES 16 B 310 ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP ALA SEQRES 17 B 310 THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY ILE SEQRES 18 B 310 THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU CYS SEQRES 19 B 310 ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO ARG SEQRES 20 B 310 ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER LYS SEQRES 21 B 310 LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS ASN SEQRES 22 B 310 TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS HIS SEQRES 23 B 310 PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL ARG SEQRES 24 B 310 ILE GLN LEU LYS ASP HIS ILE ASP ARG THR ARG HET 5DF A4000 40 HETNAM 5DF 4-{6-AMINO-5-[4-(METHYLSULFONYL)PHENYL]PYRIDIN-3- HETNAM 2 5DF YL}PHENOL FORMUL 3 5DF C18 H16 N2 O3 S FORMUL 4 HOH *35(H2 O) HELIX 1 AA1 GLU A 62 SER A 77 1 16 HELIX 2 AA2 SER A 112 THR A 120 1 9 HELIX 3 AA3 LYS A 121 THR A 124 5 4 HELIX 4 AA4 LYS A 126 HIS A 147 1 22 HELIX 5 AA5 LYS A 155 GLN A 157 5 3 HELIX 6 AA6 ALA A 196 ILE A 200 5 5 HELIX 7 AA7 ARG A 213 GLY A 229 1 17 HELIX 8 AA8 HIS A 237 ILE A 245 1 9 HELIX 9 AA9 SER A 259 LEU A 270 1 12 HELIX 10 AB1 ASN A 273 ARG A 277 5 5 HELIX 11 AB2 SER A 279 LYS A 285 1 7 HELIX 12 AB3 HIS A 286 ASP A 291 1 6 HELIX 13 AB4 ASN A 294 ARG A 308 1 15 HELIX 14 AB5 THR B 59 MET B 72 1 14 HELIX 15 AB6 ILE B 113 THR B 120 1 8 HELIX 16 AB7 LYS B 126 HIS B 147 1 22 HELIX 17 AB8 LYS B 155 GLN B 157 5 3 HELIX 18 AB9 GLN B 177 VAL B 182 1 6 HELIX 19 AC1 GLY B 183 PHE B 188 5 6 HELIX 20 AC2 ALA B 196 ILE B 200 5 5 HELIX 21 AC3 ARG B 213 GLY B 229 1 17 HELIX 22 AC4 HIS B 237 ILE B 245 1 9 HELIX 23 AC5 SER B 259 LEU B 270 1 12 HELIX 24 AC6 ASN B 273 ARG B 277 5 5 HELIX 25 AC7 SER B 279 LEU B 284 1 6 HELIX 26 AC8 HIS B 286 ASP B 291 1 6 HELIX 27 AC9 ASN B 294 ARG B 308 1 15 SHEET 1 AA1 5 PHE A 25 VAL A 30 0 SHEET 2 AA1 5 VAL A 39 HIS A 44 -1 O LYS A 41 N GLU A 29 SHEET 3 AA1 5 LEU A 50 VAL A 58 -1 O ALA A 51 N GLY A 42 SHEET 4 AA1 5 ASP A 99 GLU A 106 -1 O MET A 105 N ALA A 52 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N PHE A 89 O TRP A 102 SHEET 1 AA2 2 VAL A 159 LEU A 161 0 SHEET 2 AA2 2 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 AA3 6 LEU B 18 ARG B 19 0 SHEET 2 AA3 6 TYR B 85 LYS B 91 1 O ILE B 90 N ARG B 19 SHEET 3 AA3 6 ASP B 99 GLU B 106 -1 O GLN B 100 N LYS B 91 SHEET 4 AA3 6 LEU B 50 VAL B 58 -1 N MET B 56 O LEU B 101 SHEET 5 AA3 6 TYR B 36 HIS B 44 -1 N GLY B 42 O ALA B 51 SHEET 6 AA3 6 PHE B 25 LEU B 27 -1 N GLU B 26 O ARG B 43 SHEET 1 AA4 4 ILE B 82 ALA B 83 0 SHEET 2 AA4 4 VAL B 167 VAL B 170 1 O LEU B 169 N ALA B 83 SHEET 3 AA4 4 VAL B 159 LEU B 161 -1 N LEU B 160 O LYS B 168 SHEET 4 AA4 4 GLY B 111 SER B 112 -1 N GLY B 111 O LEU B 161 CISPEP 1 HIS A 97 ASP A 98 0 1.92 CISPEP 2 GLY B 37 GLN B 38 0 -1.07 CISPEP 3 THR B 47 GLY B 48 0 1.76 CISPEP 4 SER B 93 PRO B 94 0 -5.06 CISPEP 5 GLY B 122 ASN B 123 0 -2.55 SITE 1 AC1 13 VAL A 31 TYR A 36 VAL A 39 ALA A 52 SITE 2 AC1 13 LYS A 54 MET A 105 GLU A 106 CYS A 108 SITE 3 AC1 13 GLY A 111 ASP A 115 LEU A 160 VAL A 170 SITE 4 AC1 13 ASP A 171 CRYST1 80.600 91.740 96.620 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012407 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010900 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010350 0.00000